Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 273 clinical trials
Umbilical Cord Blood Transplant Cyclophosphamide Fludarabine and Total-Body Irradiation in Treating Patients With Hematologic Disease

This phase II trial studies how well giving an umbilical cord blood transplant together with cyclophosphamide, fludarabine, and total-body irradiation (TBI) works in treating patients with

lymphoblastic lymphoma
ejection fraction
blood disorder
total body irradiation
white blood cells
  • 125 views
  • 14 Feb, 2021
  • 3 locations
Orally Fludarabine Adriamycin and Dexamethasone (FAD) in Newly Diagnosed Peripheral T-cell Lymphomas (PTCL)

The primary objective of this study is to evaluate the efficacy of Fludarabine, Adriamycin and Dexamethasone (FAD) as first line therapy in patients with Peripheral T-cell lymphomas (PTCL

neutrophil count
absolute neutrophil count
fludarabine
large cell lymphoma
anaplastic large cell lymphoma
  • 19 views
  • 07 Nov, 2020
  • 1 location
Donor Stem Cell Transplant With Treosulfan Fludarabine and Thiotepa in Treating Patients With Non-malignant Disorders

This phase II trial studies how well donor stem cell transplant, treosulfan, fludarabine, and thiotepa work in treating patients with non-cancerous disorders. Giving chemotherapy before a donor

bone marrow procedure
primary cancer
  • 0 views
  • 14 Feb, 2021
  • 2 locations
Sorafenib Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant

This phase I/II trial studies the best dose of sorafenib when given together with busulfan and fludarabine in treating patients with acute myeloid leukemia that has come back or does not respond

cell transplantation
tacrolimus
refractory acute myeloid leukemia (aml)
cancer
ejection fraction
  • 13 views
  • 23 Jan, 2021
  • 2 locations
Fludarabine Phosphate Cyclophosphamide Total Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

This phase II trial studies how well fludarabine phosphate, cyclophosphamide, total body irradiation, and donor stem cell transplant work in treating patients with blood cancer. Drugs used in

polycythemia vera
ejection fraction
thalassemia
cytogenetic abnormalities
chronic myelomonocytic leukemia
  • 134 views
  • 24 Jan, 2021
  • 1 location
Study of Fludarabine With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer

The purpose of the study is to evaluate the efficacy and toxicity of fludarabine with pegylated liposomal doxorubicin versus pegylated liposomal doxorubicin alone in patients with platinum

cancer of the ovary
ovarian epithelial carcinoma
neutrophil count
doxorubicin
metastasis
  • 4 views
  • 21 Jan, 2021
  • 1 location
Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer

Primary Objective: The primary objective of the study is to evaluate the safety of repeat administration of a dose level of Ad/PNP plus fludarabine phosphate (F-araAMP) which demonstrated anti

  • 0 views
  • 24 Jan, 2021
  • 1 location
Donor Stem Cell Transplant With Treosulfan Fludarabine and Total-Body Irradiation for the Treatment of Hematological Malignancies

This phase II trial studies how well a donor stem cell transplant, treosulfan, fludarabine, and total-body irradiation work in treating patients with blood cancers (hematological malignancies

  • 0 views
  • 13 Feb, 2021
  • 1 location
Total Marrow and Lymphoid Irradiation Fludarabine and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome

This phase I studies the side effects and best dose of total marrow and lymphoid irradiation when given together with fludarabine and melphalan before donor stem cell transplant in treating

ejection fraction
chromosomal abnormalities
etoposide
white blood cells
leukemia
  • 17 views
  • 19 Feb, 2021
  • 1 location
Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes

The study is a Phase II clinical trial. Patients will receive intensity modulated total marrow irradiation (TMI) at a dose of 9 Gy with standard myeloablative fludarabine/ i.v. targeted busulfan

hla-a
refractory acute myeloid leukemia (aml)
tacrolimus
blast cells
flt3 internal tandem duplication
  • 6 views
  • 24 Feb, 2021
  • 1 location